Interleukin-10 genotype protects end stage renal disease patients from microinflammation and arteriosclerosis

Chinese Medical Journal

Volumn 118, Issue 18, 2005, Pages 1549-1551

  Wu, Hong Chi ^a   Ling, Hong ^a   Na, Shi Ping ^a   Xie, Ru Juan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arteriosclerosis; End stage renal disease; Interleukin 10; Micro inflammatory state

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; SILVER NITRATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC POLYMORPHISM; GENOTYPE; HEMODIALYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STAINING;

ADULT; AGED; ARTERIOSCLEROSIS; FEMALE; GENOTYPE; HUMANS; INCIDENCE; INFLAMMATION; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 26044476639     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Ye RG, Lu ZY. Internal Medicine, 6th ed. Beijing: People's Medical Publishing House; 2004:269-270.
2. Mok CC, Lanchbury JS, Chan DW, et al. Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41:1090-1095.
3. Girndt M, Sester U, Sester M, et al. The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 2001;60:2385-2391.
4. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
5. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000;343:1139-1147.